Publications

5803 Results

Local Review versus (vs) Central Review of Fluorodeoxyglucose Positron Emission Tomography (FDG-PET) in Diffuse Large B-Cell Lymphoma (DLBCL): Results from the CALGB 50303 Trial [Alliance]

Authors
A Ruppert;L Pederson;M Knopp;D Poon;J Zhang;B Kahl;JW Friedberg;L Schwartz;W Wilson;JP Leonard;N Bartlett;H Schoder
Journal / Conference
American Society of Hematology (December 5-8, 2020, virtual), poster presentation
Year
2020
Research Committee(s)
Lymphoma

SWOG S1826: A Phase III, Randomized Study of Nivolumab Plus AVD or Brentuximab Vedotin Plus AVD in Patients with Newly Diagnosed Advanced Stage Classical Hodgkin Lymphoma

Authors
A Herrera;H Li;S Castellino;S Rutherford;A Evens;K Davidson;A Punnett;L Constine;D Hodgson;S Parsons;A Prica;L Kostakoglu;M Shipp;M Leblanc;C Laubach;M Crump;B Kahl;JP Leonard;K Kelly;S Smith;JW Friedberg
Journal / Conference
American Society of Hematology (December 5-8, 2020, virtual), poster presentation
Year
2020
Research Committee(s)
Lymphoma
Study Number(s)
S1826

Evaluation of Activation of a National Cancer Trials Network (NCTN) trial for Hodgkin Lymphoma (HL) at Children’s Oncology Group (COG) Institutions

Authors
S Castellino;A Punnett;S Parsons;N Degroote;S Muehle;M Roth;A Herrera;JW Friedberg;N Siebel;K Kelly
Journal / Conference
American Society of Hematology (December 5-8, 2020, virtual), poster presentation
Year
2020
Research Committee(s)
Lymphoma
Study Number(s)
S1826

PHASE III STUDY OF DARATUMUMAB/rHuPH20 (NSC- 810307) + LENALIDOMIDE OR LENALIDOMIDE AS POST-AUTOLOGOUS STEM CELL TRANSPLANT MAINTENANCE THERAPY IN PATIENTS WITH MULTIPLE MYELOMA (MM) USING MINIMAL RESIDUAL DISEASE TO DIRECT THERAPY DURATION (DRAMMATIC STUDY): SWOG S1803

Authors
A Krishnan;A Hoering;P Hari;R Sexton;R Orlowski
Journal / Conference
American Society of Hematology (December 5-8, 2020, San Diego, CA), TIPs, poster presentation
Year
2020
Research Committee(s)
Myeloma
Study Number(s)
S1803

Emerging from COVID-19 pandemic: provider perspective on use of neoadjuvant endocrine therapy (NETI in early stage hormone receptor positive breast cancer

Authors
KU Park;M Gregory;M Lustberg;J Bazan;C Shen;S Rosenberg;V Blinder;P Sharma;L Pusztai;A Partridge;A Thompson
Journal / Conference
San Antonio Breast Cancer Symposium (December 8-12, 2020, virtual), COVID-19 Session, abst. SS2-05, poster
Year
2020
Research Committee(s)
Breast

Successful implementation of a novel trial design in a palliative care population

Authors
K Arnold;G Anderson;J Deneve;R Topacio;R Krouse
Journal / Conference
Society for Clinical Trials (virtual meeting September 1, 2020 - April 30, 2021), poster
Year
2020
Research Committee(s)
Palliative Care
Study Number(s)
S1316

New strategies to improve drug development in carcinoid tumors (Alliance A021202)

Authors
E Bergsland;S Geyer;M Mahoney;T Asmis;N Hall;S Karovic;M Knopp;P Kumthekar;A Nixon;E OReilly;L Schwartz;J Strosberg;J Meyerhardt;M Maitland
Journal / Conference
Neuroendocrine Tumor Research Foundation Research Symposium (November 2020), poster
Year
2020
Research Committee(s)
Gastrointestinal
Study Number(s)
CTSU/A021202

Female sex is a potential independent predictor of adjuvant immunotherapeutic benefit from CTLA4 immune checkpoint inhibition

Authors
A Tarhini;S Lee;S Hodi;U Rao;G Cohen;O Hamid;L Hutchins;J Sosman;H Kluger;Z Eroglu;H Koon;D Lawrence;K Kendra;D Minor;C Lee;M Albertini;L Flaherty;T Petrella;H Streicher;V Sondak;J Kirkwood
Journal / Conference
Society for Immunotherapy of Cancer (SITC) Annual Meeting (November 10-15, 2020, virtual), poster
Year
2020
Research Committee(s)
Melanoma
Study Number(s)
CTSU/E1609

The CHEK2 Variant C.349A>G Is Associated with Prostate Cancer Risk and Carriers Share a Common Ancestor

Authors
A Brandao;P Paulo;S Maia;M Pinheiro;A Peixoto;M Cardoso;C Tangen;D Albanes;M Roobol;Profile Study Steering Cmte;PRACTICAL Consortium;M Teixeira
Journal / Conference
Cancers (Basel) Nov 4;12(11):3254. doi: 10.3390/cancers12113254
Year
2020
Research Committee(s)
Cancer Control, Prevention, Screening, and Surveillance, Prevention, Screening, and and Surveillance
PMID
PMID33158149
PMC
PMC7694218
Study Number(s)
S0000, SWOG-9217

Effect of duration of adjuvant chemotherapy for patients with stage III colon cancer (IDEA collaboration): final results from a prospective, pooled analysis of six randomised, phase 3 trials

Authors
T Andre;J Meyerhardt;T Iveson;A Sobrero;T Yoshino;I Souglakos;D Niedzwiecki;M Saunders;R Labianca;T Yamanaka;I Boukovinas;D Vernerey;J Meyers;A Harkin;V Torri;E Georgoulias;E Oki;J Taieb;AF Shields;Q Shi
Journal / Conference
Lancet Oncology Dec;21(12):1620-1629. doi: 10.1016/S1470-2045(20)30527-1.
Year
2020
Research Committee(s)
Gastrointestinal
PMID
PMID33271092
PMC
PMC7786835
Study Number(s)
CTSU/C80702